Retinaldehyde if your skin tolerates it, bakuchiol if it doesn't. The one good head-to-head trial compared bakuchiol with retinol — not retinaldehyde — and found them comparable over 12 weeks with less scaling and stinging. Retinaldehyde is the more potent retinoid and has its own instrument-measured trials. Both evidence bases are small, short and partly industry-funded, and both measure appearance.
| Compared on | Retinaldehyde | Bakuchiol |
|---|---|---|
| Evidence grade | Moderate evidence | Moderate evidence |
| What it is | Retinaldehyde (also called retinal or RAL) is a naturally occurring metabolite of vitamin A and the direct biosynthetic precursor of all-trans retinoic acid, the retinoid that binds nuclear retinoic-acid receptors to regulate keratinocyte proliferation and differentiation and dermal collagen… | Bakuchiol is a meroterpene phenol extracted from the seeds and leaves of the plant Psoralea corylifolia (babchi), long used in traditional Indian Ayurvedic and Chinese medicine. |
| Best human evidence | “both retinaldehyde creams afforded significant textural improvements, reduced water loss, increased hydration” J Cosmet Dermatol 2018 · PMID 29663701 | “bakuchiol is comparable with retinol in improving photoageing and is better tolerated” Br J Dermatol 2018 · PMID 29947134 |
| Dose / protocol studied | 0.05–0.1% topical, applied nightly | 0.5% twice daily (the head-to-head RCT regimen) |
| Typical listed price | $31.99 | $30.00 |
| Who it suits | Someone who wants retinoid activity with better tolerability than prescription tretinoin and will use it nightly for months. | Someone who cannot tolerate retinoids, or who wants a product usable in the daytime without retinol's photosensitivity. |
| Who should skip it | Anyone with reactive skin who has already failed retinol, and anyone expecting an effect on systemic aging rather than appearance. | Anyone who wants decades of data behind them — reviewers describe bakuchiol as promising but not yet proven against the retinoid literature. |
| Key caveat | Several small RCTs (n = 23–40, 8–12 weeks) show objective, instrument-measured improvements in wrinkles, texture and pigmentation, with less irritation than prescription tretinoin — one cream matched a series of glycolic-acid peels. Trials are short, small and often industry-linked, and they measure appearance, not systemic aging. | One solid 12-week RCT found 0.5% bakuchiol comparable to 0.5% retinol for photoaging with less scaling and stinging, but the total evidence base is small, short and partly industry-funded. Bakuchiol is not a retinoid, and deep-wrinkle or long-term efficacy is unproven. Tolerability is its clearest advantage. |
Retinaldehyde lists at about 1.1× the price of Bakuchiol. Prices are the typical listed prices in our catalog, not live Amazon prices, and a true cost-per-studied-dose is not shown because our catalog does not record servings per container — we would have to guess, so we don't.
Bakuchiol is not a retinoid. It behaves like one in gene-expression profiling, which is a different kind of claim from the one retinoids have earned.
Retinaldehyde. It converts to retinoic acid in a single enzymatic step, making it more potent than retinol while causing less irritation than retinoic acid itself. Randomized trials at 0.05–0.1% report improvements in fine lines, texture and hydration.
Bakuchiol. The 12-week randomized double-blind trial found 0.5% bakuchiol comparable to 0.5% retinol for wrinkles and hyperpigmentation, with significantly less scaling and stinging. Tolerability is its clearest and best-established advantage.
Bakuchiol. Its reported advantages include possible daytime use without the photosensitivity associated with retinol. Sunscreen still applies either way.
Retinaldehyde, and set expectations. Deep-wrinkle and long-term efficacy for bakuchiol are unproven. Retinaldehyde's own trials are relatively few, small and short, and much of the deepest mechanistic evidence comes from retinoic acid and retinol rather than retinaldehyde directly.
These trials measure appearance — wrinkle depth, texture, pigmentation, elasticity — not systemic aging. Critical reviews caution that high-quality clinical evidence for cosmeceutical retinoids, as distinct from prescription tretinoin, remains limited, and bakuchiol's systematic reviews note that most trials are unblinded, use combination formulations and carry a high risk of bias.
The intervention with the strongest evidence in this whole category is not on this page: daily sun protection. It is graded Strong on this site.
Each quote below is taken verbatim from the cited paper. Null and negative results are included on purpose — they are the reason a grade means anything.
“both retinaldehyde creams afforded significant textural improvements, reduced water loss, increased hydration”
“Retinaldehyde is efficient and well tolerated for the improvement of the signs of photoaging”
“The natural retinoids ROL and RAL do have a good tolerance profile, in contrast with the irritating potential of RA.”
“bakuchiol is comparable with retinol in improving photoageing and is better tolerated”
“The results showed that, after 12 weeks treatment, significant improvement in lines and wrinkles, pigmentation, elasticity, firmness and overall reduction in photo-damage was observed, without usual retinol therapy-associated undesirable effects.”
“In in vivo studies, BAK was used alone or in combination with other products resulting in a significant reduction in photodamage, hyperpigmentation, wrinkle scores, and acne severity.”
Links go to an Amazon search for the product name, not to a specific listing, so you can compare sellers, price and third-party testing yourself.
In one 12-week randomized double-blind trial, yes — comparable for wrinkles and hyperpigmentation with less scaling and stinging. That trial compared it with retinol, not with retinaldehyde, and the total bakuchiol evidence base is small, short and partly industry-funded.
Yes. Retinaldehyde is the direct precursor of retinoic acid and converts in a single enzymatic step, giving greater potency than retinol while remaining better tolerated than retinoic acid.
Its reported advantages include daytime use without the photosensitivity associated with retinol. Daily sunscreen remains the highest-evidence step in any routine.
Retinaldehyde trials used 0.05–0.1% applied nightly. The bakuchiol head-to-head trial used 0.5% twice daily.
Retinaldehyde, if you are choosing one. In an eight-week trial a retinaldehyde cream matched a course of…
Curcumin has the deeper evidence base for joint symptoms — a meta-analysis of eleven meta-analyses found…
For the narrow job of raising blood NAD⁺ they look interchangeable — a 2026 randomized trial testing both…